Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Lisa D. Edwards"'
Autor:
Diane L. Zwicke, Ricardo Restrepo-Jaramillo, Hassan Alnuaimat, Kathryn Gordon, Meredith Broderick, Lisa D. Edwards, Andrew Allmon, Peter J. Leary
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
Oral treprostinil has recently been shown to delay disease progression in patients with pulmonary arterial hypertension in a long-term outcomes study. The potential advantages of an oral formulation have resulted in patients transitioning from inhale
Externí odkaz:
https://doaj.org/article/a964eba315d444f1852c279cc5f9d1c8
Autor:
Adriano R. Tonelli, Sandeep Sahay, Kathryn W. Gordon, Lisa D. Edwards, Andrew G. Allmon, Meredith Broderick, Andrew C. Nelsen
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
The 2015 European Society of Cardiology/European Respiratory Society treatment guidelines recommend frequent risk assessment in pulmonary arterial hypertension utilizing risk variables. Our objectives were: (1) to investigate the impact of inhaled tr
Externí odkaz:
https://doaj.org/article/af3fedd789fb4cadadbfe261be8513a4
Autor:
Sudarshan Rajagopal, Lana Melendres-Groves, Andrew Nelsen, Aaron B. Waxman, Eric Shen, Peter M. Smith, David J. De La Zerda, Amy Case, Shilpa Johri, Christopher S. King, Sandeep Sahay, Hilary M. DuBrock, Steven D. Nathan, Lisa D. Edwards, Victor F. Tapson
Publikováno v:
The Lancet Respiratory Medicine. 9:1266-1274
Summary Background INCREASE was a randomised, placebo-controlled, phase 3 trial that evaluated inhaled treprostinil in patients with interstitial lung disease (ILD) and associated pulmonary hypertension. Treprostinil improved exercise capacity from b
Autor:
Lisa D. Edwards, Ricardo Restrepo, Melissa Micelli, Jason Scoggin, Peter M. Smith, Trushil G. Shah, Shelley Shapiro, Joanna Joly, Leslie Spikes
Publikováno v:
Chest. 160:A2328-A2329
Autor:
Pete Smith, Andrew Nelsen, Aaron B. Waxman, Eric Shen, Steven D. Nathan, Victor F. Tapson, Lisa D. Edwards, Amy Case, Sandeep Sahay, Hilary M. DuBrock, Lana Melendres-Groves, David J. De La Zerda, Christopher S. King, Sudarshan Rajagopal, Shilpa Johri
Publikováno v:
SSRN Electronic Journal.
Background: INCREASE was a multicenter, randomized, double-blind, placebo-controlled, 16-week study that evaluated the safety and efficacy of inhaled treprostinil in patients with interstitial lung disease and associated pulmonary hypertension (PH-IL
Autor:
Alvar Agustí, Lisa D Edwards, Stephen I Rennard, William MacNee, Ruth Tal-Singer, Bruce E Miller, Jørgen Vestbo, David A Lomas, Peter M A Calverley, Emiel Wouters, Courtney Crim, Julie C Yates, Edwin K Silverman, Harvey O Coxson, Per Bakke, Ruth J Mayer, Bartolome Celli, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37483 (2012)
Because chronic obstructive pulmonary disease (COPD) is a heterogeneous condition, the identification of specific clinical phenotypes is key to developing more effective therapies. To explore if the persistence of systemic inflammation is associated
Externí odkaz:
https://doaj.org/article/7cf85a7a11e44db19f9eaf7ef5f936ff
Autor:
Erick Borg, Ricardo Restrepo, Pete Smith, Victor F. Tapson, Ashwin Ravichandran, Lisa D. Edwards, Aaron B. Waxman, Thenappan Thenappan, Steven D. Nathan
Publikováno v:
Chest. 158:A2179-A2180
Autor:
Lisa D. Edwards, Adriano R. Tonelli, Sandeep Sahay, Kathryn Gordon, Andrew Nelsen, Andrew G. Allmon
Publikováno v:
B55. USE YOUR ILLUSION I: CLINICAL RESEARCH IN PAH.
Autor:
Jørgen Vestbo, Alvar Agusti, Lisa D. Edwards, Tara Renae Rheault, Keele E. Wurst, Ruth Tal-Singer
Publikováno v:
European Respiratory Journal. 47:1559-1562
ECLIPSE offers an opportunity to examine ACOS in a large well-characterised COPD cohort followed over 3 years http://ow.ly/Zcycr
Publikováno v:
Respiratory Medicine. 109:54-62
Summary Background We evaluated the dose–response of umeclidinium (UMEC; a long-acting muscarinic antagonist) combined with fluticasone furoate (FF; an inhaled corticosteroid [ICS]) in patients with asthma. Methods In a double-blind, three-period c